帕金森症Synaptojanin-1中的Sac域突变会影响iPSC衍生的多巴胺基神经元中的状物质
Nisha Mohd Rafiq1,2,3,4, Kenshiro Fujise1,2,3,4, Martin Shaun Rosenfeld1,2,3,4
1Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
bioRxiv : the preprint server for biology
|October 24, 2023
概括
与帕金森症相关的Synaptojanin-1 (SJ1) 功能障碍损害了多巴胺神经元功能,并增加了眼长度. 这表明SJ1对于神经中的蛋白质清除至关重要,影响信号传递.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 赛纳普托宁-1 (SJ1) 是一种关键的酶,可以调节神经元中的内细胞分裂.
- 一种特定的SJ1突变 (R258Q) 导致帕金森症和神经缺陷,特别是影响多巴胺 (DA) 神经元.
- DA神经元对受损的SJ1功能表现出独特的脆弱性,这种脆弱性可以通过缩性神经终端来证明.
研究的目的:
- 调查SJ1对DA神经元内细胞分裂和眼的影响.
- 检查SJ1在神经内蛋白质动态中的作用.
- 了解SJ1对DA神经元中纤毛介导信号传递的影响.
主要方法:
- 使用来自SJ1淘汰赛 (KO) 和SJ1R258Q淘汰赛 (RQKI) 模型的诱导多能干细胞 (iPSC) 衍生的DA神经元.
- 分析了在神经末端的内细胞因子集群.
- 评估神经长度和蛋白质组成,包括Cav1.3通道和无处不在链.
主要成果:
- 突变SJ1的DA神经元表现出增强的内细胞因子聚类.
- 无论是SJ1 KO和SJ1 RQKI DA神经元,都显示了毛长度的增加.
- 在SJ1 RQDA神经元中,神经积累了Cav1.3和乌比奎丁,表明蛋白质清除受损.
- SJ1定位在底部的焦点,这表明它在内细胞形成中发挥了作用.
结论:
- SJ1在调节神经内蛋白质动态方面发挥着关键作用,特别是在DA神经元中.
- 功能受损的SJ1可能会导致皮中的蛋白质清除有缺陷,原因是皮底部的内细胞功能障碍.
- 纤毛介导蛋白质运输和信号的这种功能障碍可能会对像帕金森氏症这样的神经退行性疾病产生影响.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.6K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
相关概念视频
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
